샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774886

세계의 gRNA(가이드 RNA) 시장

gRNA
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 475 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

gRNA(가이드 RNA) 세계 시장은 2030년까지 16억 달러에 달할 전망

2024년에 5억 7,290만 달러로 추정되는 gRNA 세계 시장은 분석 기간인 2024-2030년에 CAGR 18.5%로 성장하여 2030년에는 16억 달러에 달할 것으로 예측됩니다. gRNA 최종 제품은 이 보고서에서 분석한 부문 중 하나로 CAGR은 18.0%를 기록하며 분석 기간 종료시에는 9억 7,720만 달러에 달할 것으로 예측됩니다. gRNA 합성 제품 부문의 성장률은 분석 기간 동안 CAGR 20.1%로 추정됩니다.

미국 시장은 1억 5,610만 달러, 중국은 CAGR 24.2%로 성장 예측

미국의 gRNA 시장은 2024년에 1억 5,610만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 3억 5,290만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 24.2%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 각각 분석 기간 동안에 13.8%와 16.6%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 14.7%로 성장할 것으로 예측됩니다.

세계 gRNA 시장 - 주요 동향 및 촉진요인 정리

CRISPR 유전자 편집의 보급으로 gRNA 시장 확대?

CRISPR-Cas9 기술의 등장은 유전자 편집에 혁명을 가져왔고, 가이드 RNA(gRNA) 시장의 큰 성장을 견인하고 있습니다. gRNA는 CRISPR 베이스의 유전자 편집 시스템의 중요한 구성요소이며, Cas9 효소를 특정 유전자 서열에 유도하여 정확한 변형을 수행합니다. 유전자 연구, 농업, 치료제 개발에 CRISPR 기술의 적용이 증가함에 따라 고품질의 맞춤형 gRNA 분자에 대한 수요가 증가하고 있습니다. 연구자들은 합성 및 시험관 내 전사 gRNA를 활용하여 편집 효율을 높이고, 오프 타겟 효과를 줄이고, 유전자 변형의 정확도를 향상시키고 있습니다. 또한, 염기교정 및 프라임 편집과 같은 차세대 유전자 편집 시스템의 출현으로 첨단 분자생물학적 응용에서 gRNA의 역할이 더욱 확대되고 있습니다. 오프타겟 활성, 윤리적 문제, 규제적 문제 등의 과제는 여전히 남아있지만, CRISPR 기술의 지속적인 발전은 최적화된 고충실도 gRNA 솔루션에 대한 수요를 촉진할 것으로 예상됩니다.

AI와 계산생물학은 어떻게 gRNA 설계를 강화하는가?

인공지능(AI)과 계산생물학은 gRNA 설계에 변화를 가져와 표적 특이성을 향상시키고 의도하지 않은 돌연변이를 감소시키고 있습니다. 기계학습 알고리즘은 오프타겟 효과를 최소화한 최적의 gRNA 서열을 예측하기 위해 채택되어 CRISPR 기반 유전자 편집의 성공률을 높이고 있습니다. 클라우드베이스의 바이오인포매틱스 플랫폼과 유전체 와이드 스크립팅 툴을 통해 연구자들은 gRNA 서열을 빠르게 설계하고 검증할 수 있어 유전자 연구 속도가 빨라지고 있습니다. 또한, gRNA 합성 및 스크리닝에 AI 기반 자동화를 통합함으로써 생명공학 기업 및 학술 기관의 비용을 절감하고 접근성을 향상시키고 있습니다. 이러한 기술 발전에도 불구하고, gRNA의 효율성 편차 및 종합적인 검증 연구의 필요성 등의 과제는 여전히 남아있습니다. 그러나 AI 기반 유전자 편집 도구가 계속 발전함에 따라, 생명공학 및 의료 분야에서의 gRNA 애플리케이션의 정확성과 효율성이 크게 향상될 것으로 기대됩니다.

gRNA가 치료용 유전자 편집에서 중요한 역할을 할 수 있을까?

유전자 치료와 맞춤의료에 대한 관심이 높아지면서 치료용 gRNA 기반 유전자 편집 솔루션에 대한 수요가 증가하고 있습니다. 겸상 적혈구증, 듀셴형 근이영양증, 유전성 실명증과 같은 유전성 질환을 대상으로 하는 CRISPR 기반 치료는 질병을 유발하는 돌연변이를 교정하기 위해 정밀하게 설계된 gRNA 서열에 의존하고 있습니다. 또한, gRNA는 면역치료에도 중요한 역할을 하고 있으며, 암 치료를 위한 인공 T세포 치료를 가능하게 하고 있습니다. 제약사들은 CRISPR 기반 신약개발에 투자하고 있으며, gRNA를 이용해 유전자 녹아웃을 개발하고, 새로운 치료 표적을 발굴하기 위한 기능유전체학 연구를 진행하고 있습니다. 그러나 유전자 편집의 면역반응, 전달 메커니즘, 장기적 영향 등에 대한 우려가 임상 적용에 대한 과제로 남아있습니다. 이러한 어려움에도 불구하고, gRNA의 최적화 및 전달 전략의 지속적인 발전은 재생의료 및 치료용 유전자 편집 분야에서 보다 폭넓게 채택될 수 있는 길을 열어줄 것으로 기대됩니다.

gRNA 시장 성장의 원동력은?

gRNA 시장의 성장은 CRISPR 유전자 편집의 응용 확대, AI 기반 gRNA 설계의 발전, 유전자 치료 연구에 대한 투자 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 합성생물학 및 정밀의료의 부상으로 맞춤형 고특이성 gRNA 서열에 대한 수요가 증가하고 있습니다. 또한, 형질을 강화한 유전자 변형 작물 개발을 목적으로 하는 CRISPR 기반 농업 생명공학 기술의 채택 확대가 시장 확대에 기여하고 있습니다. gRNA는 프라임 편집, 후성유전체 편집 등 차세대 유전자 편집 기술에 통합되어 생명과학 분야에서 활약의 폭을 더욱 넓혀가고 있습니다. 규제 불확실성, 윤리적 문제 등의 과제가 남아있지만, CRISPR 기술의 지속적인 혁신은 고품질 gRNA에 대한 수요를 촉진하고 최첨단 유전자 연구 및 치료 응용 분야에서 gRNA의 역할을 강화할 것으로 예상됩니다.

부문

제품 및 서비스(gRNA 최종 제품, gRNA 합성 제품, 커스텀 gRNA 합성 서비스), gRNA 유형(연구용 유형, GMP 등급 유형), 용도(유전체 공학 용도, 질환 모델 연구 용도, 기능유전체학 용도, 후생유전학 용도, 기타 용도), 최종 용도(제약·바이오테크놀러지 기업 최종 용도, 학술연구기관 최종 용도, CMO·CRO 최종 용도)

조사 대상 기업 사례

  • Addgene
  • Agilent Technologies
  • BioCat GmbH
  • Bioneer Corporation
  • Bio-Rad Laboratories
  • GeneCopoeia, Inc.
  • GENEWIZ(Azenta Life Sciences)
  • GenScript Biotech Corporation
  • Horizon Discovery Group plc
  • Integrated DNA Technologies(IDT)
  • MilliporeSigma(Merck KGaA)
  • New England Biolabs
  • OriGene Technologies
  • Qiagen N.V.
  • Santa Cruz Biotechnology
  • Synthego Corporation
  • System Biosciences(SBI)
  • Takara Bio Inc.
  • Thermo Fisher Scientific
  • VectorBuilder Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.31

Global gRNA Market to Reach US$1.6 Billion by 2030

The global market for gRNA estimated at US$572.9 Million in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 18.5% over the analysis period 2024-2030. gRNA Final Products, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$977.2 Million by the end of the analysis period. Growth in the gRNA Synthesis Products segment is estimated at 20.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$156.1 Million While China is Forecast to Grow at 24.2% CAGR

The gRNA market in the U.S. is estimated at US$156.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$352.9 Million by the year 2030 trailing a CAGR of 24.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.8% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global gRNA Market - Key Trends & Drivers Summarized

Is the Growing Popularity of CRISPR Gene Editing Expanding the gRNA Market?

The rise of CRISPR-Cas9 technology has revolutionized gene editing, driving significant growth in the guide RNA (gRNA) market. gRNA is a crucial component of CRISPR-based gene editing systems, directing the Cas9 enzyme to specific genetic sequences for precise modifications. The increasing application of CRISPR technology in genetic research, agriculture, and therapeutic development is fueling demand for high-quality, customizable gRNA molecules. Researchers are leveraging synthetic and in vitro-transcribed gRNA to enhance editing efficiency and reduce off-target effects, improving the precision of genetic modifications. Additionally, the emergence of next-generation gene editing systems, such as base editing and prime editing, is further expanding the role of gRNA in advanced molecular biology applications. While challenges such as off-target activity, ethical concerns, and regulatory hurdles persist, the continuous advancement of CRISPR technology is expected to drive the demand for optimized and high-fidelity gRNA solutions.

How Is AI and Computational Biology Enhancing gRNA Design?

Artificial intelligence (AI) and computational biology are transforming gRNA design, improving target specificity and reducing unintended mutations. Machine learning algorithms are being employed to predict optimal gRNA sequences with minimal off-target effects, enhancing the success rate of CRISPR-based gene editing. Cloud-based bioinformatics platforms and genome-wide screening tools are enabling researchers to rapidly design and validate gRNA sequences, accelerating the pace of genetic research. Additionally, the integration of AI-driven automation in gRNA synthesis and screening is reducing costs and increasing accessibility for biotech companies and academic institutions. Despite these technological advancements, challenges such as variability in gRNA efficiency and the need for comprehensive validation studies remain. However, as AI-powered gene editing tools continue to evolve, they are expected to significantly improve the precision and efficiency of gRNA applications in biotechnology and medicine.

Can gRNA Play a Crucial Role in Therapeutic Gene Editing?

The increasing focus on gene therapy and personalized medicine is driving demand for gRNA-based gene editing solutions in therapeutic applications. CRISPR-based treatments targeting genetic disorders such as sickle cell disease, Duchenne muscular dystrophy, and inherited blindness rely on precisely designed gRNA sequences to correct disease-causing mutations. Additionally, gRNA is playing a critical role in immunotherapy, enabling engineered T-cell therapies for cancer treatment. Pharmaceutical companies are investing in CRISPR-based drug discovery, using gRNA to develop gene knockouts and functional genomics studies for identifying novel therapeutic targets. However, concerns regarding immune responses, delivery mechanisms, and long-term effects of gene editing pose challenges for clinical translation. Despite these hurdles, the ongoing advancements in gRNA optimization and delivery strategies are expected to pave the way for broader adoption in regenerative medicine and therapeutic gene editing.

What Is Driving the Growth of the gRNA Market?

The growth in the gRNA market is driven by several factors, including the expanding applications of CRISPR gene editing, advancements in AI-driven gRNA design, and increasing investments in gene therapy research. The rise of synthetic biology and precision medicine is fueling demand for customizable and high-specificity gRNA sequences. Additionally, the growing adoption of CRISPR-based agricultural biotechnology, aimed at developing genetically modified crops with enhanced traits, is contributing to market expansion. The integration of gRNA in next-generation gene editing techniques, such as prime editing and epigenome editing, is further expanding its scope in life sciences. While challenges such as regulatory uncertainties and ethical concerns persist, continuous innovation in CRISPR technologies is expected to drive the demand for high-quality gRNA, reinforcing its role in cutting-edge genetic research and therapeutic applications.

SCOPE OF STUDY:

The report analyzes the gRNA market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Services (gRNA Final Products, gRNA Synthesis Products, Custom gRNA Synthesis Services); gRNA Type (Research-Use Type, GMP-Grade Type); Application (Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application, Epigenetics Application, Other Applications); End-Use (Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use, CMOs & CROs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Addgene
  • Agilent Technologies
  • BioCat GmbH
  • Bioneer Corporation
  • Bio-Rad Laboratories
  • GeneCopoeia, Inc.
  • GENEWIZ (Azenta Life Sciences)
  • GenScript Biotech Corporation
  • Horizon Discovery Group plc
  • Integrated DNA Technologies (IDT)
  • MilliporeSigma (Merck KGaA)
  • New England Biolabs
  • OriGene Technologies
  • Qiagen N.V.
  • Santa Cruz Biotechnology
  • Synthego Corporation
  • System Biosciences (SBI)
  • Takara Bio Inc.
  • Thermo Fisher Scientific
  • VectorBuilder Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • gRNA - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of CRISPR-Cas9 Gene Editing Technology Spurs Demand for gRNA in Genetic Research and Therapeutic Applications
    • Surge in Investment and Funding for Genetic Engineering and Biotechnology Drives Market Growth for gRNA Solutions
    • The Growing Application of gRNA in Agricultural Biotechnology Expands Market Opportunities in Crop Improvement and Pest Resistance
    • Rising Demand for Personalized Medicine and Targeted Therapies Propels the Adoption of gRNA in Precision Medicine
    • Technological Advancements in RNA Synthesis and Production Strengthen the Business Case for Scalable gRNA Solutions
    • Regulatory Support for Genetic Research and Genome Editing Drives Adoption of gRNA in Clinical Trials and Therapeutic Development
    • Increasing Focus on Rare Diseases and Genetic Disorders Accelerates the Demand for gRNA in Gene Therapy Applications
    • The Proliferation of Biotechnology Startups and Academic Research Institutions Expands Market Demand for Custom gRNA Solutions
    • Rising Interest in Gene Drives for Disease Eradication and Pest Control Accelerates the Adoption of gRNA in Public Health and Environmental Science
    • The Integration of Artificial Intelligence (AI) and Machine Learning in Gene Editing Strengthens the Potential of gRNA in Drug Discovery
    • Expansion of CRISPR Technology in Cancer Research and Immunotherapy Drives Demand for gRNA as a Critical Component of Therapeutic Tools
    • Increasing Commercialization of Genome Editing Technologies in Pharmaceutical and Biotech Industries Generates New Market Opportunities for gRNA
    • The Need for Efficient and Cost-Effective Gene Editing Solutions Drives the Growth of Synthetic gRNA Technologies
    • Regulatory Challenges and Ethical Considerations Around Genome Editing Accelerate Demand for Standardized and Safe gRNA Products
    • Growing Focus on Environmental and Eco-Friendly Solutions in Agricultural Biotechnology Expands the Addressable Market for gRNA Applications in Sustainable Farming
    • Surge in Research for RNA-based Therapeutics and Vaccines Drives Demand for gRNA in RNA Drug Development
    • Increasing Focus on Non-Viral Gene Delivery Systems for Gene Therapy Spurs Market Demand for gRNA in Safe and Effective Delivery Platforms
    • The Need for High-Throughput Gene Editing and Screening Drives the Adoption of gRNA in Advanced Genome Engineering Techniques
    • Rising Demand for Genetic Engineering in Livestock and Aquaculture Drives Adoption of gRNA for Animal Breeding and Disease Resistance
    • Growing Awareness of the Potential of gRNA in Regenerative Medicine and Stem Cell Therapies Expands Market Opportunities in Healthcare
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World gRNA Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for gRNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for gRNA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for gRNA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for gRNA Final Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for gRNA Final Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for gRNA Final Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for gRNA Synthesis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for gRNA Synthesis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for gRNA Synthesis Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Custom gRNA Synthesis Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Custom gRNA Synthesis Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Custom gRNA Synthesis Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Genome Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Genome Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Genome Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disease Model Studies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Disease Model Studies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Disease Model Studies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Functional Genomics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Functional Genomics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Functional Genomics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Epigenetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Epigenetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Epigenetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Research-Use Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Research-Use Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Research-Use Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for GMP-Grade Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for GMP-Grade Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for GMP-Grade Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • JAPAN
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • CHINA
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • EUROPE
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for gRNA by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for gRNA by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for gRNA by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • FRANCE
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • GERMANY
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 155: Spain Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 167: Russia Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for gRNA by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for gRNA by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for gRNA by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 206: Australia Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • INDIA
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 218: India Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for gRNA by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for gRNA by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for gRNA by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for gRNA by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for gRNA by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for gRNA by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 332: Iran Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 344: Israel Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 368: UAE Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030
  • AFRICA
    • gRNA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 392: Africa Recent Past, Current & Future Analysis for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for gRNA by Product & Services - gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for gRNA by Product & Services - Percentage Breakdown of Value Sales for gRNA Final Products, gRNA Synthesis Products and Custom gRNA Synthesis Services for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for gRNA by Application - Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for gRNA by Application - Percentage Breakdown of Value Sales for Other Applications, Genome Engineering Application, Disease Model Studies Application, Functional Genomics Application and Epigenetics Application for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for gRNA by End-Use - Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for gRNA by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Academic Research Institutes End-Use and CMOs & CROs End-Use for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for gRNA by gRNA Type - Research-Use Type and GMP-Grade Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for gRNA by gRNA Type - Percentage Breakdown of Value Sales for Research-Use Type and GMP-Grade Type for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제